Sanofi expands diabetes efforts
- April 08, 2010
French drug giant Sanofi-Aventis Thursday said it will further expand its diabetes business with an exclusive worldwide licensing deal with CureDM Group Holdings LLC for the U.S.-based biotech’s experimental treatment Pancreate. ... Read More